日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Discovery of a Novel Anticoagulant Mechanism: Factor XI Activation Inhibitors

新型抗凝机制的发现:因子XI激活抑制剂

Ellsworth, Ken; Nizner, Peter; Ogawa, Anthony; Hruza, Alan; Wei, Lan; Yang, Dexi; Lombardo, Matthew; Sonatore, Lisa; Barbieri, Christopher M; Wickham, Alexandra; Chamberlin, Chad; Nickbarg, Elliott; Richards, Matthew; Sauvagnat, Berengere; Ziebell, Michael; Ho, Thu; Ali, Amjad; Hicks, Jacqueline; Sheth, Payal; Tata, Jim

Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessus

二氢叶酸还原酶作为脓肿分枝杆菌药物靶点的药理学验证

Wassihun Wedajo Aragaw, Dereje A Negatu, Christopher J Bungard, Véronique A Dartois, Abdellatif El Marrouni, Elliott B Nickbarg, David B Olsen, Ralf Warrass, Thomas Dick

Targeting Xist with compounds that disrupt RNA structure and X inactivation

利用破坏RNA结构和X染色体失活的化合物靶向Xist

Aguilar, Rodrigo; Spencer, Kerrie B; Kesner, Barry; Rizvi, Noreen F; Badmalia, Maulik D; Mrozowich, Tyler; Mortison, Jonathan D; Rivera, Carlos; Smith, Graham F; Burchard, Julja; Dandliker, Peter J; Patel, Trushar R; Nickbarg, Elliott B; Lee, Jeannie T

Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors

氨基甲酸酯和N-嘧啶可减轻酰胺水解:基于结构的四氢喹啉IDO1抑制剂药物设计

Li, Derun; Deng, Yongqi; Achab, Abdelghani; Bharathan, Indu; Hopkins, Brett Andrew; Yu, Wensheng; Zhang, Hongjun; Sanyal, Sulagna; Pu, Qinglin; Zhou, Hua; Liu, Kun; Lim, Jongwon; Fradera, Xavier; Lesburg, Charles A; Lammens, Alfred; Martinot, Theodore A; Cohen, Ryan D; Doty, Amy C; Ferguson, Heidi; Nickbarg, Elliott B; Cheng, Mangeng; Spacciapoli, Peter; Geda, Prasanthi; Song, Xuelei; Smotrov, Nadya; Abeywickrema, Pravien; Andrews, Christine; Chamberlin, Chad; Mabrouk, Omar; Curran, Patrick; Richards, Matthew; Saradjian, Peter; Miller, J Richard; Knemeyer, Ian; Otte, Karin M; Vincent, Stella; Sciammetta, Nunzio; Pasternak, Alexander; Bennett, David Jonathan; Han, Yongxin

Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)

策略性地将极性引入血红素置换抑制剂中,以抑制吲哚胺-2,3-双加氧酶-1 (IDO1)

White, Catherine; McGowan, Meredeth A; Zhou, Hua; Sciammetta, Nunzio; Fradera, Xavier; Lim, Jongwon; Joshi, Elizabeth M; Andrews, Christine; Nickbarg, Elliott B; Cowley, Phillip; Trewick, Sarah; Augustin, Martin; von Köenig, Konstanze; Lesburg, Charles A; Otte, Karin; Knemeyer, Ian; Woo, Hyun; Yu, Wensheng; Cheng, Mangeng; Spacciapoli, Peter; Geda, Prasanthi; Song, Xuelei; Smotrov, Nadya; Curran, Patrick; Heo, Mee Ra; Abeywickrema, Pravien; Miller, J Richard; Bennett, David Jonathan; Han, Yongxin

Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase

利用高通量筛选鉴定结核分枝杆菌二氢叶酸还原酶的作用机制和新型抑制剂

Santa Maria, John P Jr; Park, Yumi; Yang, Lihu; Murgolo, Nicholas; Altman, Michael D; Zuck, Paul; Adam, Greg; Chamberlin, Chad; Saradjian, Peter; Dandliker, Peter; Boshoff, Helena I M; Barry, Clifton E 3rd; Garlisi, Charles; Olsen, David B; Young, Katherine; Glick, Meir; Nickbarg, Elliott; Kutchukian, Peter S

Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor

亲和选择质谱法鉴定出一种新型抗菌 RNA 聚合酶抑制剂

Scott S Walker, David Degen, Elliott Nickbarg, Donna Carr, Aileen Soriano, Mihir Mandal, Ronald E Painter, Payal Sheth, Li Xiao, Xinwei Sher, Nicholas Murgolo, Jing Su, David B Olsen, Richard H Ebright, Katherine Young

Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way

CSF1R 筛选化合物和抑制剂的多维分析:以更高通量的方式评估细胞活性、靶标停留时间和选择性

Joost C M Uitdehaag, Cecile M Sünnen, Antoon M van Doornmalen, Nikki de Rouw, Arthur Oubrie, Rita Azevedo, Michael Ziebell, Elliott Nickbarg, Willem-Jan Karstens, Simone Ruygrok